CSL has acquired 3 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 2 assets.
CSL’s largest acquisition to date was in 2008, when it acquired Talecris Biotherapeutics Holdings Corp for $3.1B. It’s largest disclosed sale occurred in 2005, when it sold JRH Biosciences to Sigma-Aldrich for $370M. CSL has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to CSL’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity4
- M&A Buy Activity2
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 5